Individuals who used Zicam for the relief of cold symptoms and lost their sense of smell or taste may be eligible to recover compensation. Zicam lawsuits will attempt to prove that Matrixx Initiatives failed to perform adequate testing on their product and failed to provide sufficient warnings to users regarding the product's side effects.
Zicam has been linked to a permanent or long-lasting loss of smell in users. This condition is known as anosmia. Some users lost their sense of smell after the first dose, while others experienced anosmia after taking multiple doses of the product. Zicam users have also reported a loss of sense of taste.
Zicam products are zinc-containing nasal cold remedies that are used to reduce cold symptoms. Zicam gel is delivered by a nasal spray or swab, which places zinc gluconate directly into the nasal cavity. These products are available over the counter.
Matrixx recalled Zicam Cold Remedy Swabs and Zicam Cold Remedy nasal gel in June 2009.
Zicam Cold Remedy nasal products have been associated with a permanent loss of sense of smell, also known as anosmia. These products, which are marketed by Matrixx Initiatives, are used to reduce cold symptoms. While some users lost their sense of smell after the first time they used the product, others only experienced this side effect after multiple doses. The Food and Drug Administration has received at least 130 reports of anosmia from people who have used Zicam products such as: